Ocular surface disease
Information
- Disease name
- Ocular surface disease
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT06355128 | Active, not recruiting | A Cross-sectional Study of Ocular Manifestations During the Covid-19 Pandemic in Hubei Province | January 1, 2024 | April 30, 2024 | |
| NCT06404541 | Active, not recruiting | Phase 4 | A Comparative Study Between Preservative With Benzalkonium Chloride vs Preservative Free Eye Drops on the Ocular Surface | January 10, 2024 | May 2024 |
| NCT05938985 | Active, not recruiting | Croatian Version of the Ocular Surface Disease Index Questionnaire (OSDI) | June 12, 2023 | November 2, 2023 | |
| NCT01254370 | Completed | Phase 2 | Safety and Efficacy Study of Catioprost® (Unpreserved Latanoprost 0.005% Emulsion) Compared to Travatan Z® to Treat Glaucoma and Ocular Surface Disease | November 2010 | June 2011 |
| NCT01552174 | Completed | Management of Eyelid Disorders by Ophthalmologists in Usual Medical Practice | March 2012 | April 2014 | |
| NCT00346450 | Completed | Phase 3 | Autologous ex Vivo Conjunctival Epithelial Cell Expansion for Ocular Surface Transplantation | October 2001 | December 2003 |
| NCT00554411 | Completed | Assessing Ocular Surface Changes After Changing Glaucoma Medications | November 2007 | August 2011 | |
| NCT01178242 | Completed | N/A | Salivary Gland Transplantation in the Treatment of Dry Eye in Patients With Stevens-Johnson Syndrome. | December 2008 | December 2010 |
| NCT03923244 | Completed | N/A | Dry Eye Syndrome Description During Cataract Surgery, With Multimodal Analysis of the Ocular Surface | April 1, 2019 | March 6, 2020 |
| NCT03945071 | Completed | N/A | The Effect of Punctal Plugs on Ocular Surface After Povidone-Iodine Preparation of Intravitreal Injection | June 1, 2019 | October 18, 2020 |
| NCT03968731 | Completed | N/A | Meibomian Gland Dysfunction Management With ZEST Protocol | June 10, 2019 | May 31, 2020 |
| NCT04133311 | Completed | Phase 3 | A Phase III Multinational Multicenter Investigator-Masked Randomized Active-Controlled Trial Comparing the Efficacy and Safety of DE-130A With Xalatan® in Patients With Open-Angle Glaucoma or Ocular Hypertension | April 10, 2019 | October 26, 2022 |
| NCT04351100 | Completed | Efficacy of Diacerein on Ocular Surface Disease in Degenerative Arthritis Patients | October 1, 2019 | July 31, 2020 | |
| NCT04452279 | Completed | N/A | Ocular Surface Disease Changes After iStent or iStent Inject Implantation With Phacoemulsification | May 1, 2018 | August 15, 2019 |
| NCT04493658 | Completed | Differential Diagnosis of Sjögren's Versus Non-Sjögren's Dry Eye | January 11, 2021 | October 3, 2022 | |
| NCT04535388 | Completed | N/A | LK Scleral Lens for Patients With Intractable Ocular Surface Diseases | May 1, 2012 | April 22, 2014 |
| NCT04536129 | Completed | N/A | Effects of Topical Low Dose Preservative-free Hydrocortisone on Intraocular Pressure | November 4, 2019 | March 4, 2020 |
| NCT04649177 | Completed | N/A | Pilot Study to Investigate the Feasibility, Reliability and Efficacy of Utilizing OCT to Automate PROSE Fitting | December 15, 2020 | March 23, 2022 |
| NCT04673604 | Completed | N/A | From Preserved, to Preservative-free Cyclosporine 0.1% Enhanced Triple Glaucoma Therapy | May 6, 2018 | June 29, 2020 |
| NCT04812951 | Completed | Early Phase 1 | Cyclosporine 0.1% Eye Drops as Prophylactic Treatment In Cataract Surgery | February 17, 2021 | February 23, 2022 |
| NCT04828057 | Completed | Preservative-free Fixed-dose Combination of Tafluprost 0.0015% / Timolol 0.5% in Patients With Open-angle Glaucoma or Ocular Hypertension: Clinical Effectiveness, Tolerability and Safety in a Real World Setting | September 1, 2021 | August 24, 2022 | |
| NCT04918823 | Completed | Phase 1/Phase 2 | Novel Use of Cyclosporine Ophthalmic Emulsion 0.05% on Application of PROSE Devices for Management of Patients With Ocular Surface Disease | July 15, 2021 | April 14, 2023 |
| NCT04949295 | Completed | Evaluation of Ocular Surface in Hemodialysis Patients by Ocular Surface Analyzer | January 1, 2021 | December 31, 2021 | |
| NCT04960696 | Completed | Effect on Ocular Surface Symptoms of Online Education | April 14, 2021 | June 20, 2021 | |
| NCT05319470 | Completed | Ocular Surface Disease and IOP Monitoring With Travoprost Without Conservatives | March 15, 2022 | May 15, 2023 | |
| NCT05528016 | Completed | N/A | Short and Long-term Results of Skin Versus Skin Plus Orbicularis Resection Blepharoplasty | May 1, 2021 | August 1, 2022 |
| NCT05832996 | Completed | Phase 4 | Cool vs Room-temperature Artificial Tears | March 1, 2022 | July 6, 2022 |
| NCT06013436 | Completed | AST Combined With 0.05% Cyclosporin Eye Drop Improve Corneal Nerve Density in Patients With SS Dry Eye | June 1, 2022 | June 1, 2023 | |
| NCT02656394 | Completed | Phase 2 | Amelioration of Adverse Ocular Side Effects of Glaucoma Medications in Glaucoma Patients Using Topical GL101 | January 22, 2016 | December 30, 2018 |
| NCT02802137 | Completed | Phase 4 | 24-hour Efficacy and Ocular Surface With Talfuprost and Triple Combined Therapy | March 2015 | January 2016 |
| NCT02999035 | Completed | Validation of a Newly Developed Liquid Jet Aesthesiometer | January 2017 | June 2017 | |
| NCT03302273 | Completed | N/A | Corneal Epithelial Stem Cells and Dry Eye Disease | February 1, 2019 | April 1, 2022 |
| NCT03364322 | Completed | Influencing Factors on Dry Eye Syndrome and Ocular Surface Disease | June 1, 2016 | June 30, 2017 | |
| NCT03659955 | Completed | N/A | Autologous Blood Treatment for Ocular Surface Disease | November 7, 2017 | March 14, 2019 |
| NCT03686059 | Completed | Phase 4 | Outcome of Omega 3 FA and Punctal Plugs on Ocular Surface Disease | July 2, 2018 | November 20, 2019 |
| NCT03769454 | Completed | Phase 1 | A Phase I Study of PP-001 Eye Drops in Healthy Adult Volunteers | November 20, 2018 | March 15, 2022 |
| NCT06370585 | Not yet recruiting | Phase 1 | Clinical Study to Evaluate the Safety and Tolerability of PRO-229 Ophthalmic Solution Compared to Lagricel® Ofteno PF | May 30, 2024 | September 30, 2024 |
| NCT06427629 | Not yet recruiting | N/A | Investigator-initiated Clinical Trial to Observe Conjunctival Goblet Cell Using an Anterior Segment Imaging Device | June 2024 | June 2026 |
| NCT06375343 | Not yet recruiting | Phase 1 | Study to Evaluating PRO-240 Ophthalmic Solution Compared to Optive® | October 30, 2024 | June 2025 |
| NCT04010422 | Recruiting | Ocular Function in Autism Spectrum Disorder | May 15, 2019 | December 31, 2023 | |
| NCT05195801 | Recruiting | Optic Nerve Diameter and Intraocular Pressure Changes in Patients Undergoing Vitrectomy Under General Anesthesia | January 1, 2022 | September 1, 2024 | |
| NCT04354545 | Recruiting | Treatment of Ocular Discomfort in Glaucoma Patients Using Multiple Topical Medications | April 1, 2021 | June 1, 2024 | |
| NCT06298890 | Recruiting | The Pattern of Dry Eye Disease After Cataract Surgery | March 2024 | September 2027 | |
| NCT06256770 | Recruiting | Evaluation of the Safety and Efficacy of Rigid Breathable Scleral Contact Lenses for the Correction of Ametropia | November 1, 2022 | December 1, 2024 | |
| NCT00348114 | Suspended | Phase 2 | Transplantation of Cultivated Limbal Epithelium on Amniotic Membrane for Limbal Stem Cell Deficiency | May 2002 | May 2006 |
| NCT03591874 | Terminated | Phase 3 | Study of Brimonidine Tartrate Nanoemulsion Eye Drops in Patients With Ocular Graft-vs-Host Disease | December 23, 2018 | April 30, 2020 |
| NCT01942421 | Unknown status | Phase 2/Phase 3 | Ocular Surface Reconstruction With Cultivated Autologus Mucosal Epithelial Transplantation | January 2008 | December 2013 |
| NCT04530864 | Unknown status | Phase 4 | Pre-Surgical Ocular Surface Treatment With Intracanalicular Dexamethasone Insert And Effect On Intraocular Lens Measurement Accuracy | January 2021 | July 2021 |
| NCT02894489 | Unknown status | N/A | Changes of Visual Function, Ocular Surface Structures and Physiology After Long-Termed Contact Lens Wear | August 2016 | August 2019 |
| NCT05247099 | Unknown status | Pediatric Eye Care Investigated Team | February 2022 | July 2022 | |
| NCT04608084 | Unknown status | Phase 4 | Platelet Rich Plasma Eye Drops for Treatment of Ocular Surface Disease | January 2021 | January 2023 |
| NCT04067973 | Unknown status | Impact of Prematurity on the Optic Nerve | September 2, 2019 | September 2, 2020 | |
| NCT01284439 | Unknown status | N/A | Hydroxypropylmethylcellulose 0.3% and Sodium Hyaluronate 0.18% for Ocular Surface Disease in Glaucoma | January 2011 | February 2012 |
| NCT05145959 | Unknown status | N/A | Meibomian Gland Probing in the Sub-Acute Phase of Patients With Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis | December 1, 2021 | March 1, 2024 |
| NCT01630551 | Withdrawn | N/A | Omega 3 Supplementation and Ocular Surface Disease in Glaucoma | April 2012 | February 2017 |
| NCT04735510 | Withdrawn | Phase 3 | Novel Use of Restasis and PROSE Devices | May 2021 | September 2021 |